Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 7/20 | 0.59 |
| ▸ | NPY4R | P50391 | 7/20 | 0.59 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.59 |
| ▸ | NPY1R | P25929 | 5/20 | 0.59 |
| ▸ | EP300 | Q09472 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.57 |
| ▸ | TFPI | P10646 | 3/20 | 0.56 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.55 |
| ▸ | NMUR1 | Q9HB89 | 3/20 | 0.55 |
| ▸ | KDM1A | O60341 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29551993 | 0.91 | NPY2R (0.63) | NPY2RNPY4RNPY5RNPY1REP300 | |
| SCHEMBL29360416 | 0.90 | NPY2R (0.66) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL30199009 | 0.86 | MAPK8 (0.59) | NTSR1 | |
| SCHEMBL31012331 | 0.86 | MAPK8 (0.64) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL30335722 | 0.86 | TFPI (0.64) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL30906476 | 0.85 | NPY2R (0.71) | NPY2RNPY4RNPY5RNPY1REP300 | |
| SCHEMBL31670651 | 0.85 | NTSR1 (0.56) | NPY2RNPY4RNPY5RNPY1REP300 | |
| SCHEMBL8780544 | 0.85 | NTSR1 (0.59) | NPY2RNPY4RNPY5RNPY1RNTSR1 | |
| SCHEMBL8780556 | 0.85 | NTSR1 (0.59) | NPY2RNPY4RNPY5RNPY1RNTSR1 | |
| SCHEMBL29359777 | 0.85 | NPY2R (0.63) | NPY2RNPY4RNPY5RNPY1RTFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565665-B2 | Compositions and methods for controlled mRNA translation and stability | TRUSTEES OF BOSTON UNIVERSITY (US) | 2026-03-03 | — | — | US | disclosed |
| US-20250243247-A1 | CHIMERIC ANTIGEN RECEPTOR (CAR) MODULATION | TRUSTEES OF BOSTON UNIVERSITY (US) | 2025-07-31 | — | — | US | disclosed |
| US-12202863-B2 | Chimeric antigen receptor (CAR) modulation | TRUSTEES OF BOSTON UNIVERSITY (US) | 2025-01-21 | — | — | US | disclosed |
| US-12180485-B2 | Repressible control of gene expression | TRUSTEES OF BOSTON UNIVERSITY (US) | 2024-12-31 | — | — | US | disclosed |
| US-20240263193-A1 | COMPOSITIONS AND METHODS FOR CONTROLLED MRNA TRANSLATION AND STABILITY | TRUSTEES OF BOSTON UNIVERSITY (US) | 2024-08-08 | — | — | US | disclosed |
| US-20230279406-A1 | INDUCIBLE CONTROL OF GENE EXPRESSION | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-09-07 | — | — | US | disclosed |
| US-11572565-B2 | Inducible control of gene expression | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-02-07 | — | — | US | disclosed |
| US-20220098246-A1 | CHIMERIC ANTIGEN RECEPTOR (CAR) MODULATION | TRUSTEES OF BOSTON UNIVERSITY (US) | 2022-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565665-B2 | Compositions and methods for controlled mRNA translation and stability | ADAR, ADA, NSUN2 | NPY2R 4475/4885NPY4R 4647/4885NPY5R 4832/4885 |
| US-20250243247-A1 | CHIMERIC ANTIGEN RECEPTOR (CAR) MODULATION | HAVCR2, CPB1, CTRL | NPY2R 3151/4885NPY4R 3416/4885NPY5R 3573/4885 |
| US-20220098246-A1 | CHIMERIC ANTIGEN RECEPTOR (CAR) MODULATION | HAVCR2, CPB1, CTRL | NPY2R 3151/4885NPY4R 3416/4885NPY5R 3573/4885 |
| US-12202863-B2 | Chimeric antigen receptor (CAR) modulation | HAVCR2, CPB1, CTRL | NPY2R 3151/4885NPY4R 3416/4885NPY5R 3573/4885 |
| US-20240263193-A1 | COMPOSITIONS AND METHODS FOR CONTROLLED MRNA TRANSLATION AND STABILITY | ADAR, ADA, RNGTT | NPY2R 4866/4885NPY4R 4880/4885NPY5R 4868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.